Home General Biotechnology Drug Patent Expirations in August 2009

Drug Patent Expirations in August 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in August 2009


*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
BREATHTEK UBT FOR H-PYLORIOtsuka Americaurea, c-135,140,993Aug 24, 2009
COMBIVIRGlaxosmithklinelamivudine; zidovudine7,119,202Aug 8, 2009
EPIVIRGlaxosmithklinelamivudine7,119,202Aug 8, 2009
EPIVIR-HBVGlaxosmithklinelamivudine7,119,202Aug 8, 2009
EPZICOMSmithkline Beechamabacavir sulfate; lamivudine7,119,202Aug 8, 2009
EVOXACDaiichi Sankyo Cocevimeline hydrochloride4,855,290Aug 30, 2009
EXTRANEALBaxter Hlthcareicodextrin4,761,237Aug 9, 2009
LOVAZASmithkline Beechamomega-3-acid ethyl esters5,698,594Aug 4, 2009
MERETEK UBT KIT (W/ PRANACTIN)Otsuka Americaurea, c-135,140,993Aug 24, 2009
RESTASISAllergancyclosporine4,839,342Aug 2, 2009
TRIZIVIRGlaxosmithklineabacavir sulfate; lamivudine; zidovudine7,119,202Aug 8, 2009
VFENDPfizervoriconazole5,116,844Aug 11, 2009

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

NO COMMENTS

  1. GREETINGS
    I AM REALLY LUCKY TO FIND THIS SITE . PATENTS TOPIC IS HIGHLY USEFUL IN MY JOB TO PICK DRUG APPLICATIONS WHERE THE PATENT REGULATIONS ARE NOT OBSEVED. THIS DESPITE THE TRIPS REGULATIONS WHICH ARE GLOBAL .
    I THANK YOU FOR YOUR PRECIOUS HELP.YOU KNOW THAT IN THE FIELD OF DRUG REGISTRATION SHARING INTELLIGENCE AND HAVING THE RIGHT INFORMATION IS FUNDAMENTAL. AN APPLICATION WHERE THE IP REGULATIONS ARE NOT RESPECTED IS OBVIOUSLY NOT CONCERNED OF SAFETY QUALITY PURITY STABILITY OF THE API .

    SINCERE THANKS & WARM REGARDS

    MOHAMED FATHI SAFFAR Pharm.D
    VICE-DIRECTOR AT THE NATIONAL LAB FOR DRUG CONTROL .TUNIS .TUNISIA

Leave a Reply